LEADER 03123nam  2200361   450 
001 9910737282003321
005 20231104110914.0
010   $a1-68108-787-1
035   $a(CKB)4100000012152256
035   $a(NjHacI)994100000012152256
035   $a(EXLCZ)994100000012152256
100   $a20231104d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aWhat is new in gastroenterology and hepatology /$fIoan Sporea, Alina Popescu, editors
210  1$a[Place of publication not identified] :$cBentham Science,$d[2021]
215   $a1 online resource (314 pages)
311   $a1-68108-788-X 
327   $aWhat's New in Extra-digestive Gastroesophageal Reflux Disease?; Optical Diagnosis in Barrett Esophagus and Related Neoplasia; Eosinophilic Gastrointestinal Disorders; Postoperative Digestive Complications of Bariatric Surgery; What is New in Gastro-Entero-Pancreatic Neuroendocrine Tumors; Intestinal Microbiota and its Implications in Pathology; Videocapsule Endoscopy; Precision Medicine in Inflammatory Bowel Disease: Current Challenges; Fibrosis in Crohn's Disease From Evolution to Treatment; The Quality of Life of Patients with Inflammatory Bowel Disease: A Continuous Challenge; Advances in Colorectal Cancer Screening; New Guidelines on Post-polypectomy Colonoscopy Surveillance; Artificial Intelligence in Gastrointestinal Endoscopy; Gallbladder Tumors; Management of Severe Acute Pancreatitis; Endoscopic Treatment in Chronic Pancreatitis; EUS Drainage of Peripancreatic Fluid Collections; Update in the Management of Pancreatic Cysts; Emerging Techniques for Assessment of Chronic Liver Diseases: The "Omics" Cascade; Where are we Now with Ultrasound-based Liver Elastography?; New Insights into NAFLD (Diagnosis, Risk Stratification, Treatment); The Role of Cytokines and Inflammatory Mediators in Alcoholic Liver Disease; Noninvasive Assessment of Steatosis and Fibrosis in Alcoholic Liver Disease; Can we Stop Nucleos(t)ide Analogs in HBV Chronic Hepatitis?; Hepatitis C Virus and Chronic Kidney Disease What is New?; Advances in Imaging Diagnosis of Hepatocellular Carcinoma the Place of Contrast Enhanced Ultrasound (CEUS); Treatment of Intermediate Stage Hepatocellular Carcinoma from Guidelines and Beyond; Direct-acting Oral Anticoagulants in Liver Cirrhosis: What is the Current Status?; Latest Data on the Epidemiology, Pathological Classification, and Staging of the Combined Hepatocellular Carcinoma-Intrahepatic Cholan-giocarcinoma; Endoscopic Therapy in Cholangiocarcinoma; Telemedicine in Hepatology, is it Time to Move Forward?; Pathologies of the Peritoneum, Mesentery and Diaphragm; Overview of Iron Products in Gastroenterological Anemia.
606   $aGastroenterology
615  0$aGastroenterology.
676   $a616.33
702   $aSporea$b Ioan
702   $aPopescu$b Alina
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910737282003321
996   $aWhat is New in Gastroenterology and Hepatology$93553292
997   $aUNINA